Surescripts®, the nation’s leading health intelligence network, introduces its Patient Experience product, Script Corner™, to ...
Eligible patients can now get the Wegovy pill — the first oral GLP-1 treatment for weight management in adults — at Hy-Vee ...
GoodRx reports five major changes to Medicare in 2026, including a $2,100 Part D out-of-pocket limit, prior authorization for ...
SAN FRANCISCO — Surescripts is teaming up with Good Rx to surface key prescription discounts to consumers. The health information network announced Tuesday at the J.P. Morgan Healthcare Conference ...
The tariffs might be aimed at Europe, but they’re going to hit American pocketbooks.
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including GoodRx ...
Surescripts Introduces New Patient Experience Solution to Transform the Medication Experience and Improve Patient Access, Affordability and Adherence Surescripts®, the nation’s leading health ...
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that the newly FDA-approved Wegovy® pill (oral semaglutide) is ...
Analysts have recently evaluated GoodRx Holdings and provided 12-month price targets. The average target is $4.16, accompanied by a high estimate of $6.00 and a low estimate of $2.75. This current ...
GoodRx reports on tracking prescription fills for flu and COVID-19 treatments, revealing seasonal trends and insurance ...
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that the newly FDA-approved Wegovy® pill (oral semaglutide) is now available at a cash price of $149 per ...
The company’s massive pharmacy benefit manager changed its rules and weaponized audits to ensure independent pharmacies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results